Review



human coronavirus strain 229e  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 96
      Buy from Supplier

    Structured Review

    ATCC human coronavirus strain 229e
    A) Experimental protocol with sample collection at 24 and 48 hours post infection (hpi) for two duplicate experiments (A and B). For scRNA-seq, this resulted in transcriptomes from 13,913 cells across all samples, including 4,192 mock-infected and 2,724 virus-infected cells at 24 hpi and 3,593 mock-infected and 3,404 virus-infected cells at 48 hpi. B) The viral load across samples after quality control. The median log1p(viral reads) detected in 24 hpi sample A is 7.0 (SD 1.0), in 24 hpi sample B is 7.1 (SD 0.9), and across samples A and B is 7.1 (SD 1.0). The median log1p(viral reads) detected in 48 hpi sample A is 6.6 (SD 1.0), in 48 hpi sample B is 6.4 (SD 1.0), and across samples A and B is 6.5 (SD 1.0). C) Venn diagram representing the number of differentially expressed genes in a cell-level, time-matched <t>229E-infected</t> versus mock-control differential expression test at a threshold of adjusted p-value < 0.001 and |log ₂ FC| > 2.
    Human Coronavirus Strain 229e, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 785 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human coronavirus strain 229e/product/ATCC
    Average 96 stars, based on 785 article reviews
    human coronavirus strain 229e - by Bioz Stars, 2026-05
    96/100 stars

    Images

    1) Product Images from "Resolving in vitro heterogeneity of host functional responses to HCoV-229E via single-cell analyses"

    Article Title: Resolving in vitro heterogeneity of host functional responses to HCoV-229E via single-cell analyses

    Journal: bioRxiv

    doi: 10.64898/2026.04.17.719293

    A) Experimental protocol with sample collection at 24 and 48 hours post infection (hpi) for two duplicate experiments (A and B). For scRNA-seq, this resulted in transcriptomes from 13,913 cells across all samples, including 4,192 mock-infected and 2,724 virus-infected cells at 24 hpi and 3,593 mock-infected and 3,404 virus-infected cells at 48 hpi. B) The viral load across samples after quality control. The median log1p(viral reads) detected in 24 hpi sample A is 7.0 (SD 1.0), in 24 hpi sample B is 7.1 (SD 0.9), and across samples A and B is 7.1 (SD 1.0). The median log1p(viral reads) detected in 48 hpi sample A is 6.6 (SD 1.0), in 48 hpi sample B is 6.4 (SD 1.0), and across samples A and B is 6.5 (SD 1.0). C) Venn diagram representing the number of differentially expressed genes in a cell-level, time-matched 229E-infected versus mock-control differential expression test at a threshold of adjusted p-value < 0.001 and |log ₂ FC| > 2.
    Figure Legend Snippet: A) Experimental protocol with sample collection at 24 and 48 hours post infection (hpi) for two duplicate experiments (A and B). For scRNA-seq, this resulted in transcriptomes from 13,913 cells across all samples, including 4,192 mock-infected and 2,724 virus-infected cells at 24 hpi and 3,593 mock-infected and 3,404 virus-infected cells at 48 hpi. B) The viral load across samples after quality control. The median log1p(viral reads) detected in 24 hpi sample A is 7.0 (SD 1.0), in 24 hpi sample B is 7.1 (SD 0.9), and across samples A and B is 7.1 (SD 1.0). The median log1p(viral reads) detected in 48 hpi sample A is 6.6 (SD 1.0), in 48 hpi sample B is 6.4 (SD 1.0), and across samples A and B is 6.5 (SD 1.0). C) Venn diagram representing the number of differentially expressed genes in a cell-level, time-matched 229E-infected versus mock-control differential expression test at a threshold of adjusted p-value < 0.001 and |log ₂ FC| > 2.

    Techniques Used: Infection, Virus, Control, Quantitative Proteomics

    A) The median aggregated accessibility profiles centered on the transcription start sites (TSS; ±3kb) for mock and 229E-infected samples at 24 and 48 hpi. The bold lines show median and mean profiles computed over mean profiles across all samples, while lower opacity profiles show variability across replicates. B) The mean aggregated accessibility profiles centered on the transcription start sites (TSS; ±3kb) for mock and 229E-infected samples at 24 and 48 hpi. The bold lines show median and mean profiles computed over mean profiles across all samples, while lower opacity profiles show variability across replicates. C) Principal component analysis (PCA) of accessibility profiles separates mock-control and 229E infected samples at 24 and 48 hpi. Axes indicate the variance explained by each principal component, marker shapes indicate time point, and marker colors indicate infection status. D) Volcano plots of differential accessibility (infected versus mock-control) at 24 (left) and 48 (right) hpi. Each point is an open chromatin region, and blue points indicate significantly increased accessibility, while orange points indicate significantly decreased accessibility. Gray points are not significant. At 24 hpi, 6% of open chromatin regions (OCRs) show increased chromatin accessibility (blue) and 5% show decreased chromatin accessibility (orange). At 48 hpi, 20% of OCRs show increased chromatin accessibility (blue), and 13% show decreased chromatin accessibility (orange).
    Figure Legend Snippet: A) The median aggregated accessibility profiles centered on the transcription start sites (TSS; ±3kb) for mock and 229E-infected samples at 24 and 48 hpi. The bold lines show median and mean profiles computed over mean profiles across all samples, while lower opacity profiles show variability across replicates. B) The mean aggregated accessibility profiles centered on the transcription start sites (TSS; ±3kb) for mock and 229E-infected samples at 24 and 48 hpi. The bold lines show median and mean profiles computed over mean profiles across all samples, while lower opacity profiles show variability across replicates. C) Principal component analysis (PCA) of accessibility profiles separates mock-control and 229E infected samples at 24 and 48 hpi. Axes indicate the variance explained by each principal component, marker shapes indicate time point, and marker colors indicate infection status. D) Volcano plots of differential accessibility (infected versus mock-control) at 24 (left) and 48 (right) hpi. Each point is an open chromatin region, and blue points indicate significantly increased accessibility, while orange points indicate significantly decreased accessibility. Gray points are not significant. At 24 hpi, 6% of open chromatin regions (OCRs) show increased chromatin accessibility (blue) and 5% show decreased chromatin accessibility (orange). At 48 hpi, 20% of OCRs show increased chromatin accessibility (blue), and 13% show decreased chromatin accessibility (orange).

    Techniques Used: Infection, Control, Marker



    Similar Products

    human coronavirus strain 229e  (ATCC)
    96
    ATCC human coronavirus strain 229e
    A) Experimental protocol with sample collection at 24 and 48 hours post infection (hpi) for two duplicate experiments (A and B). For scRNA-seq, this resulted in transcriptomes from 13,913 cells across all samples, including 4,192 mock-infected and 2,724 virus-infected cells at 24 hpi and 3,593 mock-infected and 3,404 virus-infected cells at 48 hpi. B) The viral load across samples after quality control. The median log1p(viral reads) detected in 24 hpi sample A is 7.0 (SD 1.0), in 24 hpi sample B is 7.1 (SD 0.9), and across samples A and B is 7.1 (SD 1.0). The median log1p(viral reads) detected in 48 hpi sample A is 6.6 (SD 1.0), in 48 hpi sample B is 6.4 (SD 1.0), and across samples A and B is 6.5 (SD 1.0). C) Venn diagram representing the number of differentially expressed genes in a cell-level, time-matched <t>229E-infected</t> versus mock-control differential expression test at a threshold of adjusted p-value < 0.001 and |log ₂ FC| > 2.
    Human Coronavirus Strain 229e, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human coronavirus strain 229e/product/ATCC
    Average 96 stars, based on 1 article reviews
    human coronavirus strain 229e - by Bioz Stars, 2026-05
    96/100 stars
    		  Buy from Supplier
    test microorganism coronavirus 229e  (ATCC)
    96
    ATCC test microorganism coronavirus 229e
    A) Experimental protocol with sample collection at 24 and 48 hours post infection (hpi) for two duplicate experiments (A and B). For scRNA-seq, this resulted in transcriptomes from 13,913 cells across all samples, including 4,192 mock-infected and 2,724 virus-infected cells at 24 hpi and 3,593 mock-infected and 3,404 virus-infected cells at 48 hpi. B) The viral load across samples after quality control. The median log1p(viral reads) detected in 24 hpi sample A is 7.0 (SD 1.0), in 24 hpi sample B is 7.1 (SD 0.9), and across samples A and B is 7.1 (SD 1.0). The median log1p(viral reads) detected in 48 hpi sample A is 6.6 (SD 1.0), in 48 hpi sample B is 6.4 (SD 1.0), and across samples A and B is 6.5 (SD 1.0). C) Venn diagram representing the number of differentially expressed genes in a cell-level, time-matched <t>229E-infected</t> versus mock-control differential expression test at a threshold of adjusted p-value < 0.001 and |log ₂ FC| > 2.
    Test Microorganism Coronavirus 229e, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/test microorganism coronavirus 229e/product/ATCC
    Average 96 stars, based on 1 article reviews
    test microorganism coronavirus 229e - by Bioz Stars, 2026-05
    96/100 stars
    		  Buy from Supplier
    coating technology against human respiratory coronavirus 229e  (ATCC)
    96
    ATCC coating technology against human respiratory coronavirus 229e
    A) Experimental protocol with sample collection at 24 and 48 hours post infection (hpi) for two duplicate experiments (A and B). For scRNA-seq, this resulted in transcriptomes from 13,913 cells across all samples, including 4,192 mock-infected and 2,724 virus-infected cells at 24 hpi and 3,593 mock-infected and 3,404 virus-infected cells at 48 hpi. B) The viral load across samples after quality control. The median log1p(viral reads) detected in 24 hpi sample A is 7.0 (SD 1.0), in 24 hpi sample B is 7.1 (SD 0.9), and across samples A and B is 7.1 (SD 1.0). The median log1p(viral reads) detected in 48 hpi sample A is 6.6 (SD 1.0), in 48 hpi sample B is 6.4 (SD 1.0), and across samples A and B is 6.5 (SD 1.0). C) Venn diagram representing the number of differentially expressed genes in a cell-level, time-matched <t>229E-infected</t> versus mock-control differential expression test at a threshold of adjusted p-value < 0.001 and |log ₂ FC| > 2.
    Coating Technology Against Human Respiratory Coronavirus 229e, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/coating technology against human respiratory coronavirus 229e/product/ATCC
    Average 96 stars, based on 1 article reviews
    coating technology against human respiratory coronavirus 229e - by Bioz Stars, 2026-05
    96/100 stars
    		  Buy from Supplier
    hcov 229e  (ATCC)
    96
    ATCC hcov 229e
    A) Experimental protocol with sample collection at 24 and 48 hours post infection (hpi) for two duplicate experiments (A and B). For scRNA-seq, this resulted in transcriptomes from 13,913 cells across all samples, including 4,192 mock-infected and 2,724 virus-infected cells at 24 hpi and 3,593 mock-infected and 3,404 virus-infected cells at 48 hpi. B) The viral load across samples after quality control. The median log1p(viral reads) detected in 24 hpi sample A is 7.0 (SD 1.0), in 24 hpi sample B is 7.1 (SD 0.9), and across samples A and B is 7.1 (SD 1.0). The median log1p(viral reads) detected in 48 hpi sample A is 6.6 (SD 1.0), in 48 hpi sample B is 6.4 (SD 1.0), and across samples A and B is 6.5 (SD 1.0). C) Venn diagram representing the number of differentially expressed genes in a cell-level, time-matched <t>229E-infected</t> versus mock-control differential expression test at a threshold of adjusted p-value < 0.001 and |log ₂ FC| > 2.
    Hcov 229e, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hcov 229e/product/ATCC
    Average 96 stars, based on 1 article reviews
    hcov 229e - by Bioz Stars, 2026-05
    96/100 stars
    		  Buy from Supplier
    hcov 229e vr740  (ATCC)
    96
    ATCC hcov 229e vr740
    A) Experimental protocol with sample collection at 24 and 48 hours post infection (hpi) for two duplicate experiments (A and B). For scRNA-seq, this resulted in transcriptomes from 13,913 cells across all samples, including 4,192 mock-infected and 2,724 virus-infected cells at 24 hpi and 3,593 mock-infected and 3,404 virus-infected cells at 48 hpi. B) The viral load across samples after quality control. The median log1p(viral reads) detected in 24 hpi sample A is 7.0 (SD 1.0), in 24 hpi sample B is 7.1 (SD 0.9), and across samples A and B is 7.1 (SD 1.0). The median log1p(viral reads) detected in 48 hpi sample A is 6.6 (SD 1.0), in 48 hpi sample B is 6.4 (SD 1.0), and across samples A and B is 6.5 (SD 1.0). C) Venn diagram representing the number of differentially expressed genes in a cell-level, time-matched <t>229E-infected</t> versus mock-control differential expression test at a threshold of adjusted p-value < 0.001 and |log ₂ FC| > 2.
    Hcov 229e Vr740, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hcov 229e vr740/product/ATCC
    Average 96 stars, based on 1 article reviews
    hcov 229e vr740 - by Bioz Stars, 2026-05
    96/100 stars
    		  Buy from Supplier
    human coronavirus 229e  (ATCC)
    96
    ATCC human coronavirus 229e
    A) Experimental protocol with sample collection at 24 and 48 hours post infection (hpi) for two duplicate experiments (A and B). For scRNA-seq, this resulted in transcriptomes from 13,913 cells across all samples, including 4,192 mock-infected and 2,724 virus-infected cells at 24 hpi and 3,593 mock-infected and 3,404 virus-infected cells at 48 hpi. B) The viral load across samples after quality control. The median log1p(viral reads) detected in 24 hpi sample A is 7.0 (SD 1.0), in 24 hpi sample B is 7.1 (SD 0.9), and across samples A and B is 7.1 (SD 1.0). The median log1p(viral reads) detected in 48 hpi sample A is 6.6 (SD 1.0), in 48 hpi sample B is 6.4 (SD 1.0), and across samples A and B is 6.5 (SD 1.0). C) Venn diagram representing the number of differentially expressed genes in a cell-level, time-matched <t>229E-infected</t> versus mock-control differential expression test at a threshold of adjusted p-value < 0.001 and |log ₂ FC| > 2.
    Human Coronavirus 229e, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human coronavirus 229e/product/ATCC
    Average 96 stars, based on 1 article reviews
    human coronavirus 229e - by Bioz Stars, 2026-05
    96/100 stars
    		  Buy from Supplier

    Image Search Results


    A) Experimental protocol with sample collection at 24 and 48 hours post infection (hpi) for two duplicate experiments (A and B). For scRNA-seq, this resulted in transcriptomes from 13,913 cells across all samples, including 4,192 mock-infected and 2,724 virus-infected cells at 24 hpi and 3,593 mock-infected and 3,404 virus-infected cells at 48 hpi. B) The viral load across samples after quality control. The median log1p(viral reads) detected in 24 hpi sample A is 7.0 (SD 1.0), in 24 hpi sample B is 7.1 (SD 0.9), and across samples A and B is 7.1 (SD 1.0). The median log1p(viral reads) detected in 48 hpi sample A is 6.6 (SD 1.0), in 48 hpi sample B is 6.4 (SD 1.0), and across samples A and B is 6.5 (SD 1.0). C) Venn diagram representing the number of differentially expressed genes in a cell-level, time-matched 229E-infected versus mock-control differential expression test at a threshold of adjusted p-value < 0.001 and |log ₂ FC| > 2.

    Journal: bioRxiv

    Article Title: Resolving in vitro heterogeneity of host functional responses to HCoV-229E via single-cell analyses

    doi: 10.64898/2026.04.17.719293

    Figure Lengend Snippet: A) Experimental protocol with sample collection at 24 and 48 hours post infection (hpi) for two duplicate experiments (A and B). For scRNA-seq, this resulted in transcriptomes from 13,913 cells across all samples, including 4,192 mock-infected and 2,724 virus-infected cells at 24 hpi and 3,593 mock-infected and 3,404 virus-infected cells at 48 hpi. B) The viral load across samples after quality control. The median log1p(viral reads) detected in 24 hpi sample A is 7.0 (SD 1.0), in 24 hpi sample B is 7.1 (SD 0.9), and across samples A and B is 7.1 (SD 1.0). The median log1p(viral reads) detected in 48 hpi sample A is 6.6 (SD 1.0), in 48 hpi sample B is 6.4 (SD 1.0), and across samples A and B is 6.5 (SD 1.0). C) Venn diagram representing the number of differentially expressed genes in a cell-level, time-matched 229E-infected versus mock-control differential expression test at a threshold of adjusted p-value < 0.001 and |log ₂ FC| > 2.

    Article Snippet: Human coronavirus strain 229E (HCoV-229E) from ATCC ((#VR-740, Lot #70053995) was used for in-house virus batch propagation.

    Techniques: Infection, Virus, Control, Quantitative Proteomics

    A) The median aggregated accessibility profiles centered on the transcription start sites (TSS; ±3kb) for mock and 229E-infected samples at 24 and 48 hpi. The bold lines show median and mean profiles computed over mean profiles across all samples, while lower opacity profiles show variability across replicates. B) The mean aggregated accessibility profiles centered on the transcription start sites (TSS; ±3kb) for mock and 229E-infected samples at 24 and 48 hpi. The bold lines show median and mean profiles computed over mean profiles across all samples, while lower opacity profiles show variability across replicates. C) Principal component analysis (PCA) of accessibility profiles separates mock-control and 229E infected samples at 24 and 48 hpi. Axes indicate the variance explained by each principal component, marker shapes indicate time point, and marker colors indicate infection status. D) Volcano plots of differential accessibility (infected versus mock-control) at 24 (left) and 48 (right) hpi. Each point is an open chromatin region, and blue points indicate significantly increased accessibility, while orange points indicate significantly decreased accessibility. Gray points are not significant. At 24 hpi, 6% of open chromatin regions (OCRs) show increased chromatin accessibility (blue) and 5% show decreased chromatin accessibility (orange). At 48 hpi, 20% of OCRs show increased chromatin accessibility (blue), and 13% show decreased chromatin accessibility (orange).

    Journal: bioRxiv

    Article Title: Resolving in vitro heterogeneity of host functional responses to HCoV-229E via single-cell analyses

    doi: 10.64898/2026.04.17.719293

    Figure Lengend Snippet: A) The median aggregated accessibility profiles centered on the transcription start sites (TSS; ±3kb) for mock and 229E-infected samples at 24 and 48 hpi. The bold lines show median and mean profiles computed over mean profiles across all samples, while lower opacity profiles show variability across replicates. B) The mean aggregated accessibility profiles centered on the transcription start sites (TSS; ±3kb) for mock and 229E-infected samples at 24 and 48 hpi. The bold lines show median and mean profiles computed over mean profiles across all samples, while lower opacity profiles show variability across replicates. C) Principal component analysis (PCA) of accessibility profiles separates mock-control and 229E infected samples at 24 and 48 hpi. Axes indicate the variance explained by each principal component, marker shapes indicate time point, and marker colors indicate infection status. D) Volcano plots of differential accessibility (infected versus mock-control) at 24 (left) and 48 (right) hpi. Each point is an open chromatin region, and blue points indicate significantly increased accessibility, while orange points indicate significantly decreased accessibility. Gray points are not significant. At 24 hpi, 6% of open chromatin regions (OCRs) show increased chromatin accessibility (blue) and 5% show decreased chromatin accessibility (orange). At 48 hpi, 20% of OCRs show increased chromatin accessibility (blue), and 13% show decreased chromatin accessibility (orange).

    Article Snippet: Human coronavirus strain 229E (HCoV-229E) from ATCC ((#VR-740, Lot #70053995) was used for in-house virus batch propagation.

    Techniques: Infection, Control, Marker